These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22755137)

  • 21. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
    Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
    Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artemether-loaded polymeric lipid-core nanocapsules reduce cell viability and alter the antioxidant status of U-87 MG cells.
    Pires J; Costa SA; da Silva KP; da Conceição AGB; Reis ÉM; Sinhorin AP; Branco CLB; Cruz L; Ferrarini SR; Andrade CMB
    Pharm Dev Technol; 2022 Oct; 27(8):892-903. PubMed ID: 36168940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide.
    Hatahet T; Morille M; Shamseddin A; Aubert-Pouëssel A; Devoisselle JM; Bégu S
    Int J Pharm; 2017 Feb; 518(1-2):167-176. PubMed ID: 28011344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic activity of poly-ɛ-caprolactone lipid-core nanocapsules loaded with lycopene-rich extract from red guava (Psidium guajava L.) on breast cancer cells.
    Vasconcelos AG; Valim MO; Amorim AGN; do Amaral CP; de Almeida MP; Borges TKS; Socodato R; Portugal CC; Brand GD; Mattos JSC; Relvas J; Plácido A; Eaton P; Ramos DAR; Kückelhaus SAS; Leite JRSA
    Food Res Int; 2020 Oct; 136():109548. PubMed ID: 32846600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression.
    de Castro Leão M; Raffin Pohlmann A; de Cristo Soares Alves A; Helena Poliselli Farsky S; Klimuk Uchiyama M; Araki K; Sandri S; Stanisçuaski Guterres S; Alves Castro I
    Eur J Pharm Biopharm; 2021 Feb; 159():99-107. PubMed ID: 33358940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation and stability evaluation of bixin nanocapsules.
    Lobato KB; Paese K; Forgearini JC; Guterres SS; Jablonski A; Rios Ade O
    Food Chem; 2013 Dec; 141(4):3906-12. PubMed ID: 23993564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-Core Nanocapsules Improved Antiedematogenic Activity of Tacrolimus in Adjuvant-Induced Arthritis Model.
    Friedrich RB; Coradini K; Fonseca FN; Guterres SS; Beck RC; Pohlmann AR
    J Nanosci Nanotechnol; 2016 Feb; 16(2):1265-74. PubMed ID: 27433576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical characterization and in vitro skin permeation of solid lipid nanoparticles for transdermal delivery of quercetin.
    Han SB; Kwon SS; Jeong YM; Yu ER; Park SN
    Int J Cosmet Sci; 2014 Dec; 36(6):588-97. PubMed ID: 25220288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules.
    Lollo G; Ullio-Gamboa G; Fuentes E; Matha K; Lautram N; Benoit JP
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():859-867. PubMed ID: 30033321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoencapsulation of tacrolimus in lipid-core nanocapsules showed similar immunosuppressive activity after oral and intraperitoneal administrations.
    Friedrich RB; Dimer FA; Guterres SS; Beck RC; Pohlmann AR
    J Biomed Nanotechnol; 2014 Aug; 10(8):1599-609. PubMed ID: 25016659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dithranol-loaded lipid-core nanocapsules improve the photostability and reduce the in vitro irritation potential of this drug.
    Savian AL; Rodrigues D; Weber J; Ribeiro RF; Motta MH; Schaffazick SR; Adams AI; de Andrade DF; Beck RC; da Silva CB
    Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():69-76. PubMed ID: 25491961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity.
    Cruz L; Schaffazick SR; Dalla Costa T; Soares LU; Mezzalira G; da Silveira NP; Schapoval EE; Pohlmann AR; Guterres SS
    J Nanosci Nanotechnol; 2006; 6(9-10):3154-62. PubMed ID: 17048531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
    Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
    J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.
    Schultze E; Ourique A; Yurgel VC; Begnini KR; Thurow H; de Leon PM; Campos VF; Dellagostin OA; Guterres SR; Pohlmann AR; Seixas FK; Beck RC; Collares T
    Eur J Pharm Biopharm; 2014 May; 87(1):55-63. PubMed ID: 24525073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemocompatibility of poly(ɛ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan.
    Bender EA; Adorne MD; Colomé LM; Abdalla DSP; Guterres SS; Pohlmann AR
    Int J Pharm; 2012 Apr; 426(1-2):271-279. PubMed ID: 22322210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin-loaded poly(ϵ-caprolactone) lipid-core nanocapsules: Evaluation of fetal and maternal toxicity.
    Giacomeli R; Guerra Teixeira FE; Carvalho FB; Pacheco CO; Martins Parisotto AJ; Funguetto Ribeiro AC; Gomes de Gomes M; Haas SE
    Food Chem Toxicol; 2020 Oct; 144():111625. PubMed ID: 32738367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of poly(ε-caprolactone) lipid-core nanocapsules on melanoma-neutrophil crosstalk.
    Drewes CC; Alves AC; Hebeda CB; Copetti I; Sandri S; Uchiyama MK; Araki K; Guterres SS; Pohlmann AR; Farsky SH
    Int J Nanomedicine; 2017; 12():7153-7163. PubMed ID: 29026308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro drug release mechanism from lipid nanocapsules (LNC).
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Int J Pharm; 2010 May; 390(2):208-13. PubMed ID: 20149853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats.
    Frozza RL; Bernardi A; Paese K; Hoppe JB; da Silva T; Battastini AM; Pohlmann AR; Guterres SS; Salbego C
    J Biomed Nanotechnol; 2010 Dec; 6(6):694-703. PubMed ID: 21361135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.